Patent ID: 11945794
Assignee: KARYOPHARM THERAPEUTICS INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 10:
11. The compound of claim 10, wherein:
Rb is selected from:
—C(O)—OH; or
—C(O)—NH2; or
—C(O)—NH—NH(R6), and R6 is an optionally substituted heteroaryl; or
—C(O)—NH—NH—C(O)—R4 or —C(O)—NH—NH-S(O)1-2—R4, and R4 is selected from optionally substituted —N(H)(C3-C6 cycloalkyl), —N(C1-C4 alkyl)(C3-C6 cycloalkyl), —C1-C6 alkyl, —(C0-C4 alkylene)-heterocyclyl and —(C0-C4 alkylene)-heteroaryl.